Tongue biofilm represents a non-invasive, cost-effective, and accessible biomarker source, offering potential for AD diagnosis and research when coupled with microbiome and metabolomic analyses.
Abstract
ABSTRACT Introduction This study aimed to evaluate the feasibility of using tongue biofilm as a non-invasive, patient-friendly, and cost-effective biomarker source for identifying early microbial and metabolic disturbances associated with Alzheimer’s disease (AD). Materials and methods A total of 62 outpatients were enrolled (31 with AD and 31 cognitively normal controls). Tongue biofilm samples were analyzed using 16S rRNA sequencing and untargeted metabolomics via UPLC-Q/TOF-MS. Additionally, cerebrospinal fluid (CSF) samples from 36 individuals (18 per group) were examined under identical untargeted metabolomics processing protocols to validate the metabolomic findings. Results and discussion Microbiome analysis revealed an increased relative abundance of Proteobacteria in the AD group, while Firmicutes and Bacteroidetes were enriched in controls. Metabolomic profiling identified 88 significantly different metabolites between groups, 64 of which achieved area under the curve (AUC) values > 0.90 in the ROC analysis. Glycerophospholipid metabolism has emerged as a key dysregulated pathway in AD, a finding further corroborated by CSF metabolomic analysis. Tongue biofilm represents a non-invasive, cost-effective, and accessible biomarker source, offering potential for AD diagnosis and research when coupled with microbiome and metabolomic analyses. Moreover, the role of glycerophospholipid metabolism in AD pathogenesis warrants further investigation.
Abstract Background Few studies have comprehensively profiled both the salivary microbiome and metabolome in myocardial infarction (MI). This case-control study therefore characterized microbial and metabolic alterations in MI patients and identified potential diagnostic signatures. Methods Seventy participants (35 MI...
Sheng-Nan Lei, Tuo Chen, Xiao-Dong Xie et al.· Journal of Oral Microbiology· 0 citations
Background Mental disorders are among the leading causes of global disease burden, and their etiology spans genetic, environmental, and physiological factors. Emerging evidence suggests that the gut microbiota may contribute to the development of neuropsychiatric disorders through the microbiota–gut–brain axis. This st...
Yun-Qiang Mi, Peng Sun, Qing-Rui Hao et al.· Frontiers in Psychiatry· 0 citations
AD in this Central Asian cohort was associated with a less diverse, compositionally distinct gut microbiome, with depletion of butyrate-producing Firmicutes and enrichment of sulfate-reducing taxa, alongside other taxa whose direction of association differed from prior reports.
A. Issilbayeva, S. Kozhakhmetov, A. Kushugulova et al.· International Journal of Mol...· 0 citations
Alzheimer’s disease (AD) is increasingly studied in relation to gut microbial mechanisms because microbial metabolism, mucosal barrier function, and peripheral immune activation may influence neuroinflammation and host metabolic stress. This review evaluates microbiome-linked evidence in AD with emphasis on studies tha...
The four-metabolite panel (α-ketoglutarate, succinic acid, tryptamine, and amino butyric acid) may provide experimental basis for further mechanistic research and therapeutic development and offer peripheral evidence supporting the core position of GABAergic dysfunction in schizophrenia.
Bing Han, Yu Guo, Baie Feng et al.· Frontiers in Psychiatry· 0 citations
Integrated multi-omic profiling reveals coordinated microbiome–metabolome dysregulation across the AD clinical spectrum, with taurine as a candidate microbial–metabolic node linking gut dysbiosis to cognitive performance.
Yi Feng, Yao Sha, Lu-Lu Xu et al.· Frontiers in Aging Neuroscie...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.